| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 16.939 | 37.200 | 66.007 | 74.807 | 103.883 |
| Total Income - EUR | - | - | - | - | - | 16.939 | 37.200 | 66.007 | 74.807 | 103.883 |
| Total Expenses - EUR | - | - | - | - | - | 2.488 | 5.681 | 18.530 | 19.412 | 18.549 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 14.451 | 31.520 | 47.477 | 55.396 | 85.334 |
| Net Profit/Loss - EUR | - | - | - | - | - | 13.975 | 30.426 | 45.941 | 54.685 | 82.685 |
| Employees | - | - | - | - | - | 0 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Boleacgyn S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 4 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 14.131 | 32.010 | 48.070 | 64.677 | 128.857 |
| Inventories | - | - | - | - | - | 0 | 0 | 322 | 1.753 | 2.444 |
| Receivables | - | - | - | - | - | 1.034 | 23.563 | 35.385 | 40.255 | 121.928 |
| Cash | - | - | - | - | - | 13.097 | 8.447 | 12.362 | 22.669 | 4.486 |
| Shareholders Funds | - | - | - | - | - | 14.016 | 30.466 | 45.990 | 54.733 | 103.550 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 118 | 1.543 | 2.079 | 9.944 | 25.307 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Boleacgyn S.r.l.